Total Funding
66
74
Total FundingVenture - Series Unknown raised
Growth Score
-2 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
118497
Onegene Biotechnology develops highly potent tri- or intraspecific protein-based drugs.
- Josh H. Hwang: CFOPast Role: Celltrion, Head of IR
- Sungjin Park: CEOPast Role: Northwestern University, Post-doctoral associate
About the Company
Onegene Biotechnology is a biotechnology company that develops highly potent tri- or intraspecific protein-based drugs. It allows an unlimited combination of different types of molecules, such as Fab fragment, scFv, sdAb, peptide, cytokines, agonist/antagonist, or enzymes. The unprecedented design flexibility with optimized physical properties
opens new design space for multispecific protein drugs with CMC feasibility.
